Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age

BACKGROUND: Universal immunization of adolescents against meningococcal disease with a quadrivalent meningococcal ACWY (MenACWY) conjugate vaccine is recommended in a number of countries. METHODS: In a randomized, controlled, observer-blinded, multicenter trial, 1016 participants, 10–25 years of age...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Scott A., Baine, Yaela, Domachowske, Joseph B., Aggarwal, Naresh, Simon, Michael, Langley, Joanne M., McNeil, Shelly A., Friedland, Leonard R., Bianco, Veronique, Baccarini, Carmen I., Miller, Jacqueline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933042/
https://www.ncbi.nlm.nih.gov/pubmed/24567843
http://dx.doi.org/10.1093/jpids/pit058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933042/
https://www.ncbi.nlm.nih.gov/pubmed/24567843
http://dx.doi.org/10.1093/jpids/pit058

Ejemplares similares